| HAL : inserm-00696112, version 1 |
| PubMed : 22566635 |
| PubMed Central : 3361440 |
| DOI : 10.1073/pnas.1120210109 |
| Fiche détaillée | Récupérer au format |
|
|
| Proceedings- National Academy of Sciences Usa 109, 21 (2012) 7974-81 |
|
|
|
|
| A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. |
|
|
| Patrícia B. S. Celestino-Soper 1Sara Violante 2, 3 |
|
|
| (22/05/2012) |
|
|
| We recently reported a deletion of exon 2 of the trimethyllysine hydroxylase epsilon (TMLHE) gene in a proband with autism. TMLHE maps to the X chromosome and encodes the first enzyme in carnitine biosynthesis, 6-N-trimethyllysine dioxygenase. Deletion of exon 2 of TMLHE causes enzyme deficiency, resulting in increased substrate concentration (6-N-trimethyllysine) and decreased product levels (3-hydroxy-6-N-trimethyllysine and γ-butyrobetaine) in plasma and urine. TMLHE deficiency is common in control males (24 in 8,787 or 1 in 366) and was not significantly increased in frequency in probands from simplex autism families (9 in 2,904 or 1 in 323). However, it was 2.82-fold more frequent in probands from male-male multiplex autism families compared with controls (7 in 909 or 1 in 130; P = 0.023). Additionally, six of seven autistic male siblings of probands in male-male multiplex families had the deletion, suggesting that TMLHE deficiency is a risk factor for autism (metaanalysis Z-score = 2.90 and P = 0.0037), although with low penetrance (2-4%). These data suggest that dysregulation of carnitine metabolism may be important in nondysmorphic autism; that abnormalities of carnitine intake, loss, transport, or synthesis may be important in a larger fraction of nondysmorphic autism cases; and that the carnitine pathway may provide a novel target for therapy or prevention of autism. |
|
|
|
|
|
|
|
|
|
|
| 1 : | Department of Molecular and Human Genetics |
| Baylor College of Medicine | |
| 2 : | Metabolism and Genetics Group |
| Research Institute for Medicines and Pharmaceutical Sciences – Universidade de Lisboa | |
| 3 : | Laboratory Genetic Metabolic Disease |
| Academic Medical Center – University of Amsterdam | |
| 4 : | Department of Molecular Physiology and Biophysics |
| Centers for Human Genetics Research and Molecular Neuroscience – Vanderbilt University | |
| 5 : | Department of Human Genetics |
| University of California, Los Angeles – Semel Institute | |
| 6 : | The Centre for Applied Genomics and Program in Genetics and Genomic Biology |
| The Hospital for Sick Children | |
| 7 : | Physiopathologie des Maladies du Système Nerveux Central |
| INSERM : U952 – Université Pierre et Marie Curie [UPMC] - Paris VI – CNRS : UMR7224 | |
| 8 : | Seaver Autism Research Center |
| Mount Sinai School of Medicine | |
| 9 : | Department of Neurology |
| Johns Hopkins University | |
| 10 : | Texas Children's Hospital |
| Texas Children's Hospital | |
| 11 : | Department of psychiatry |
| Baylor College of Medicine | |
| 12 : | Department of Psychiatry and Behavioural Neurosciences |
| McMaster University | |
| 13 : | Autism Research Unit |
| The Hospital for Sick Children and Bloorview Kids Rehabilitation – University of Toronto | |
| 14 : | Disciplines of Genetics and Medicine |
| Memorial University of Newfoundland | |
| 15 : | Greenwood Genetic Center |
| Greenwood Genetic Center | |
| 16 : | Departments of Psychiatry and Genetics |
| Yale University School of Medicine | |
| 17 : | Department of Psychiatry |
| Institute for Juvenile Research – University of Illinois at Chicago | |
| 18 : | Department of pediatrics |
| Baylor College of Medicine | |
|
|
|
|
|
|
|
|
| domaine | : | Sciences du Vivant/Génétique |
|
|
| Liste des fichiers attachés à ce document : | ||||||||||
|
|
|
| inserm-00696112, version 1 | |
| http://www.hal.inserm.fr/inserm-00696112 | |
| oai:www.hal.inserm.fr:inserm-00696112 | |
| Contributeur : Catalina Betancur | |
| Soumis le : Jeudi 10 Mai 2012, 19:44:08 | |
| Dernière modification le : Mardi 7 Août 2012, 13:17:32 | |